Member Info for Timster

I'd imagine the contracts have already gone to some random Tory mates who've created a shell company on having the heads up of free money available.

Boom, he's back, Hurstbot garbage at its best!!!

It's thought he works for Avacta with the extensive calls made that are never wrong.

What about the size buyers though ice they'll be tucking into their turkey rather than size buying, it'll be carnage.

Eggy you really are crap at this now.

We'll find out in tomorrow's RNS.

They always come within 48hrs of a sujood prediction, never been wrong.

Agreed PL75 and JT. FDA approval will take as long as it takes.

This QC of data is taking a bloody long time though 😉

As I just posted in parallel to completion is a very weird sentence.

Could me it runs after

Just reread the RNS, it's not planed to run with C7 it's planned to run when it finishes - "in parallel with the completion of cohort 7". So a weird way of saying the 2 week study will start after the completion of C7?

'Therefore, in parallel with the completion of cohort 7, the Company intends to begin a short study to explore more frequent dosing (fortnightly) of AVA6000 as a first line treatment in patients with soft tissue sarcoma"

If the 2 weekly study is to run parallel to cohort 7 then perhaps they expected cohort 7 to be a long one as it is definitely the last one.

Pure speculation obviously.

I find it odd Bella for a savvy investor you somehow believe Sujood has inside info, bonkers

And then there's Hurstbot, most advanced AI ever seen.

100+ RNSs I think we've all guessed a few right.

Each to thier own though you're clearly a believer and disciple.

yes

just because i take the **** out of sujood and his delusional insider information doesn't mean i work for 🐶💩🪨🦷.

i'm a very long term holder am very well researched and very very happy that the pre|cision platform works and we await for the data to prove it once and for all.

Yes in Q4 I'm expecting at least 2

Should be ashamed of himself.

Only 7 days (today included) left in November.

We've spoken about this....

Three people recommended "."

🙄

Https://twitter.com/MylesMcNulty/status/1726929190526521399?t=zQraK8Zb8wSIA9MOIl2AHA&s=19

Predicting RNSs there's only one poster we trust for that !

A patient seeing benefits though would remain on treatment (at the same level) once the cohort ended. I presume.

What if they have an STS patient in C7 also seeing significant reduction in tumour size, will they then wait to add this to the data set.

I presume the patient who saw a significant reduction in the last cohort would have also continued treatment and may be included as a case study.